Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection

Lancet Reg Health West Pac. 2023 Apr 4:33:100759. doi: 10.1016/j.lanwpc.2023.100759. eCollection 2023 Apr.
No abstract available